Jazz Pharmaceuticals plc
JAZZ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001232524
In the last 90 days, Jazz Pharmaceuticals plc insiders filed 0 open-market purchases and 6 sales; 648 institutions reported holding it in 13F filings for Q2 2026, worth $15.5B in total; no superinvestor holds it.
Holders of 5% or more of JAZZ
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Jazz Pharmaceuticals plc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 13G | 5.04%3.10M shares | New | Apr 30, 20261 filing | Apr 30, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Jazz Pharmaceuticals plc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 6, 202610:31 AM ET | FMR LLCand 1 other | 13G | 7.40%4.68M shares | New | Jun 30, 2026 | SEC |
| Apr 30, 202611:19 AM ET | Vanguard Capital Management LLC | 13G | 5.04%3.10M shares | New | Mar 31, 2026 | SEC |
| Mar 27, 202610:20 AM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Jazz Pharmaceuticals plc shares.
No Form 144 notices for Jazz Pharmaceuticals plc are on file.